All In Biotech

Drug Trial Radar · NCT05317819

Study of ADI-PEG 20 Versus Placebo in Subjects With High Arginine Level and Unresectable Hepatocellular Carcinoma

A Randomized, Double-Blind, Multi-Center Study of ADI-PEG 20 Versus Placebo in Subjects With High Arginine Level and Unresectable Hepatocellular Carcinoma

Last checked: Nov 19, 2026Latest source record: Dec 18, 2025 (this record)Source: ClinicalTrials.govMethods & limitations

RecruitingPivotal-lookingPhase 3. Randomized with 300 participants. This is a heuristic, not a regulatory label.

Status

Recruiting

Enrollment

300

Planned (sponsor's estimate)

Start

Mar 14, 2022

Primary completion

Sep 2028

Study completion Dec 2028

Sponsor

Lead sponsor
Polaris GroupIndustry
Sponsor type
Industry
First posted
Apr 8, 2022

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Triple (participant, care provider, investigator)
Primary purpose
Treatment
FDA-regulated drug
No
Who can join
All sexes, from 18 years, up to 99 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

Evaluate efficacy and safety of ADI-PEG 20 in patients with high-argininephenotypic and HCC

Conditions

  • Hepatocellular Carcinoma
  • Advanced Hepatocellular Carcinoma

Interventions

  • ADI-PEG20Drug

    Treatment for hepatocellular carcinoma

  • PlaceboOther

    Treatment for hepatocellular carcinoma

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Overall Survival (OS)Time frame: Approximately 18 months

Locations

11 sites in 2 countries. Site status is shown where the registry gives one.

  • Changhua Christian Hospital (CCH)

    Changhua, Taiwan · Recruiting

  • Ditmanson Medical Foundation Chiayi Christian Hospital (CYCH)

    Chiayi City, Taiwan · Recruiting

  • Chang Gung Medical Foundation-Chia-Yi (CGMF-CY)

    Chiayi City, Taiwan · Recruiting

  • Kaohsiung Medical University Chung-Ho Memorial Hospital (KMUH)

    Kaohsiung City, Taiwan · Recruiting

  • Chang Gung Medical Foundation-Kaohsiung(CGMF-KS)

    Kaohsiung City, Taiwan · Recruiting

  • Chi Mei Medical Center (CMMC-YK)

    Tainan, Taiwan · Recruiting

  • Chi Mei Hospital, Liouying (CMMC-LY)

    Tainan, Taiwan · Recruiting

  • Chang Gung Medical Foundation-Linkou (CGMF-LK)

    Taoyuan, Taiwan · Recruiting

  • K Hospital

    Hà Nội, Vietnam · Not yet recruiting

  • Bach Mai Hospital

    Hanoi, Vietnam · Not yet recruiting

  • Hue Central Hospital

    Huế, Vietnam · Not yet recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.